A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review

被引:1
作者
Roberta Cardoso
Natalie G. Coburn
Rajini Seevaratnam
Alyson Mahar
Lucy Helyer
Calvin Law
Simron Singh
机构
[1] Sunnybrook Health Sciences Centre,Sunnybrook Research Institute
[2] Sunnybrook Health Sciences Centre,Division of Surgical Oncology
[3] Odette Cancer Centre,Department of Community Health and Epidemiology
[4] Queen’s University,Department of Surgery
[5] Dalhousie University,Department of Medical Oncology/Hematology
[6] Sunnybrook Health Sciences Centre and Odette Cancer Centre,undefined
来源
Gastric Cancer | 2012年 / 15卷
关键词
Gastric cancer; Follow-up; Systematic review; Resection; Surveillance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:164 / 167
页数:3
相关论文
共 62 条
[1]  
Marrelli D(2005)Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg 241 247-255
[2]  
De Stefano A(2007)Value of intensive follow-up of patients after curative surgery for gastric carcinoma J Surg Oncol 96 503-506
[3]  
de Manzoni G(2007)Surveillance program for recurrence after curative gastric cancer surgery Chir Gastroenterol 23 392-398
[4]  
Morgagni P(2009)On behalf of the ESMO Guidelines Working Group. Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 iv34-6
[5]  
Di Leo A(2002)Guidelines for the management of oesophageal and gastric cancer Gut 50 v1-v23
[6]  
Roviello F(2005)Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? J Am Coll Surg 201 503-510
[7]  
Tan IT(2000)Detection and prognosis of recurrent gastric cancer—is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology 47 1489-1494
[8]  
So BYJ(2003)Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit Ann Surg Oncol 10 898-902
[9]  
Mikani K(2009)Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma Int J Biol Markers 24 258-264
[10]  
Yamashita Y(2010)Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet 376 687-697